New Guidelines Offer Comprehensive Approach to Dyslipidemia Management

Updated recommendations for the evaluation, management, and monitoring of dyslipidemia – including high cholesterol, hypertriglyceridemia, and elevated lipoprotein(a) – were released on March 13, 2026, by the American College of Cardiology (ACC), the American Heart Association (AHA), and nine other leading medical associations.

A ‘One-Stop Shop’ for Dyslipidemia

The 2026 ACC/AHA Guideline on the Management of Dyslipidemia consolidates evidence-based recommendations, retiring and replacing the 2018 Guideline on the Management of Blood Cholesterol. It aims to provide a comprehensive resource for healthcare professionals addressing dyslipidemias.

Early Intervention is Key

A major focus of the new guidelines is earlier intervention, beginning with healthy lifestyle changes in youth. Pharmacotherapy should be considered in young people with familial hypercholesterolemia and in young adults with LDL-C levels of 160 mg/dL or higher, or with a strong family history of premature atherosclerotic cardiovascular disease (ASCVD).

Updated Risk Assessment Tools

The guideline recommends using the American Heart Association’s PREVENT equations, rather than the older Pooled Cohort Equations, for 10- and 30-year risk assessment to guide lipid-lowering therapy (LLT) in primary prevention for adults aged 30 to 79 years.

LDL-Lowering Therapy Recommendations

LDL-lowering therapy is reasonable for adults in primary prevention of ASCVD with a borderline 10-year PREVENT-ASCVD risk estimate of 3% to less than 5%, and is recommended for those with an intermediate 10-year PREVENT ASCVD risk of 5% to less than 10% following a discussion between the clinician and patient.

Guideline Leadership

The guideline was developed under the direction of Roger Blumenthal, M.D., FACC, FAHA, chair of the writing committee and director of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease.

“While we want to attempt to optimize healthy lifestyle habits as the first step to lower cholesterol, we realize that if lipid numbers aren’t within the desirable range after a period of lifestyle optimization, we should consider adding lipid-lowering medication earlier than we would have considered 10 years ago,” Blumenthal said in a statement.